Lyra Therapeutics (LYRA) Equity Average (2019 - 2025)

Quarterly Equity Average fell 146.7% to -$7.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.5 million through Dec 2025, down 146.7% year-over-year, with the annual reading at $438500.0 for FY2025, 99.13% down from the prior year.

Lyra Therapeutics' Equity Average history spans 7 years, with the latest figure at -$7.5 million for Q4 2025.

  • Equity Average came in at -$7.5 million for Q4 2025, down from -$1.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $99.7 million in Q3 2022 to a low of -$7.5 million in Q4 2025.
  • The 5-year median for Equity Average is $58.4 million (2021), against an average of $51.1 million.
  • Year-over-year, Equity Average surged 412.95% in 2021 and then plummeted 146.7% in 2025.
  • Lyra Therapeutics' Equity Average stood at $40.8 million in 2021, then surged by 113.46% to $87.0 million in 2022, then fell by 0.18% to $86.8 million in 2023, then crashed by 81.45% to $16.1 million in 2024, then tumbled by 146.7% to -$7.5 million in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Equity Average are -$7.5 million (Q4 2025), -$1.4 million (Q3 2025), and $2.7 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 3.76 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 19.01 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 31.34 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 932.28 Mn
10 Lyra Therapeutics - - - -7.52 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -7.52 Mn
Sep 30, 2025 -1.36 Mn
Jun 30, 2025 2.74 Mn
Mar 31, 2025 7.73 Mn
Dec 31, 2024 16.11 Mn
Sep 30, 2024 25.80 Mn
Jun 30, 2024 54.24 Mn
Mar 31, 2024 83.46 Mn
Dec 31, 2023 86.83 Mn
Sep 30, 2023 91.41 Mn
Jun 30, 2023 82.33 Mn
Mar 31, 2023 73.42 Mn
Dec 31, 2022 86.99 Mn
Sep 30, 2022 99.74 Mn
Jun 30, 2022 64.75 Mn
Mar 31, 2022 28.79 Mn
Dec 31, 2021 40.75 Mn
Sep 30, 2021 52.34 Mn
Jun 30, 2021 62.53 Mn
Mar 31, 2021 71.02 Mn
Dec 31, 2020 77.70 Mn
Sep 30, 2020 83.87 Mn
Jun 30, 2020 -19.98 Mn
Mar 31, 2020 -125.06 Mn
Dec 31, 2019 -121.17 Mn
Sep 30, 2019 -116.93 Mn
Jun 30, 2019 -112.77 Mn